Singapore HSA registration DE0502963
Immucor immuClone Rh-Hr Control
Device classification
- Device Class
- CLASS D IVD
- Medical Speciality Area
- Hematology
Registration information
- Registration Number
- DE0502963
- Registration Date
- April 03, 2019
- Retention Due Date
- April 02, 2026
Product description
immuClone Rh-Hr Control Reagent is used for parallel testing with ImmuClone IgM monoclonal blood grouping antisera to indicate if the antisera could give a false positive result due to abnormalities of the sample such as autoantibodies, positive direct antiglobulin test or protein abnormalities.
Product Owner
- Short Name
- Immucor Medizinische Diagnostik GmbH
- Address
- Robert-Bosch-Strasse 32, DREIEICH, 63303, Germany, GERMANY
Registrant
- Address
- 18 BOON LAY WAY, TRADEHUB 21, #05-105, SINGAPORE 609966
Importer
- Address
- 18 BOON LAY WAY, TRADEHUB 21, #05-105, SINGAPORE 609966
Model information
- Model Name(s)
- immuClone Rh-Hr Control immuClone Rh-Hr Control immuClone Rh-Hr Control (Galileo) immuClone Rh-Hr Control (Galileo)
- Model Identifier(s)
- 0006720 0006721 0066006 0066083
About this record
Access comprehensive regulatory information for Immucor immuClone Rh-Hr Control in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0502963 and owned by Immucor Medizinische Diagnostik GmbH. The device was registered on April 03, 2019.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS D IVD